Drugs & TargetsFree Rucaparib receives FDA approval for BRCA-mutated metastatic castration-resistant prostate cancer May 22, 2020Vol.46 No.21
Drugs & TargetsFree Ripretinib receives FDA approval for advanced gastrointestinal stromal tumor May 22, 2020Vol.46 No.21
Drugs & TargetsFree Tecentriq receives FDA approval as first-line monotherapy in NSCLC indication May 22, 2020Vol.46 No.21
Drugs & TargetsFree Olaparib receives FDA approval for HRR gene-mutated metastatic castration-resistant prostate cancer May 22, 2020Vol.46 No.21
Drugs & TargetsFree BRACAnalysis CDx receives approval as companion diagnostic for Lynparza in mCRPC indication May 22, 2020Vol.46 No.21
Drugs & TargetsFree Karyopharm submits sNDA for Xpovio as treatment for multiple myeloma after at least one prior line of therapy May 22, 2020Vol.46 No.21
Clinical RoundupFree Flatiron Health, Foundation Medicine, Genentech to launch novel prospective lung cancer clinical study May 22, 2020Vol.46 No.21
Clinical RoundupFree Advanced prostate cancer rates continued to rise after USPSTF guideline change May 22, 2020Vol.46 No.21
Clinical RoundupFree Study: Text messages are ineffective reminders to maintain AI regimens May 22, 2020Vol.46 No.21
FreeFunding Opportunities Hope Foundation announces John Crowley award for statistical excellence in cancer clinical trials May 22, 2020Vol.46 No.21
